CD274 and pancreatic neoplasm: The overexpression of PD-L1 in cancers such as gastric carcinoma, hepatocellular carcinoma, renal-cell carcinoma, esophageal carcinoma, pancreatic cancer, ovarian cancer, and bladder cancers is associated with poor clinical outcomes, and the detection of its levels has important clinical significance 1.